MedTrace Logo

Psychosocial ADHD Interventions - Brief Parent Training

NCT05452954 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-01-10

No results posted yet for this study

Summary

This pilot study investigates a new, easily applicable, individually tailored first-line behavioral training for parents of children (4-12 years) with (symptoms of) ADHD, that will be provided in an early stage, before other treatments have been applied. In this pilot study the feasibility of the newly developed intervention will be evaluated by exploring program acceptability, including client satisfaction, recruitment, retention, treatment fidelity and therapist satisfaction. Also acceptability of potential outcome measures will be explored, including preliminary tests of efficacy.

Conditions

  • ADHD
  • ADHD - Combined Type
  • ADHD Predominantly Inattentive Type
  • ADHD, Predominantly Hyperactive-Impulsive Type
  • Behavior Problem
  • Behavioral Problem
  • Problem Behavior
  • Behavioral Symptoms
  • Child Behavior Problem
  • Disruptive Behavior

Interventions

BEHAVIORAL

Brief behavioral parent training

In the newly developed intervention, both stimulus control and contingency management techniques will be offered in a brief behavioral parent training consisting of two intervention sessions and one booster session.

Sponsors & Collaborators

  • Accare

    lead OTHER

Principal Investigators

  • B. J. Van den Hoofdakker, Prof. dr. · Accare

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
4 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-16
Primary Completion
2023-04-06
Completion
2023-04-06

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05452954 on ClinicalTrials.gov